PathoQuest, Charles River Laboratories Partner
News Sep 30, 2016
PathoQuest has announced a preferred partnership with Charles River Laboratories to provide an improved Viral Safety Service offering to biopharmaceutical companies. While traditional molecular approaches to safety testing are limited to the identification of a limited, predefined list of viruses, the PathoQuest’s next generation sequencing (NGS) solution combines a proprietary curated virus database with an automated analysis pipeline. This provides a universal test for identifying viruses of any type in a single, comprehensive analysis that minimizes false negatives.
“We are very pleased to enter into this partnership with PathoQuest and look forward to offering this unique NGS-based testing solution to our customers,” stated Horst Ruppach, Global Director, Viral Clearance and Virology at Charles River Laboratories. “We believe this advanced viral safety testing solution is an important supplement to ensuring the safety of biological products produced by the biopharmaceutical industry.”
“Charles River’s global footprint and extensive experience in biologics testing opens a great opportunity for biopharmaceutical companies to access our NGS-based solutions,” said Jean-François BREPSON, President and CEO of PathoQuest. “In a challenging regulatory environment, we anticipate that PathoQuest’s NGS-based viral safety test will become the new gold standard in biosafety assessment.”
With this partnership agreement, PathoQuest demonstrates its unique know-how and expertise in the field of pathogen identification with a fully-integrated, NGS-based metagenomics process for identifying pathogens from biological specimens and samples and the delivery of an actionable report. In the wake of viral contaminants of several high-profile marketed biological products, the biopharmaceutical industry is increasingly looking for improved methods for viral safety testing of biological products such as monoclonal antibodies or vaccines.
SMi’s 5th Annual Molecular Diagnostics Conference 2018 Agenda ReleasedNews
SMi proudly presents its 5th annual conference on Molecular Diagnostics, taking place at the Holiday Inn Kensington Forum, London, UK on 9th and 10th July 2018, with a half-day post-conference workshops on 11th July 2018.READ MORE
Early Life-Changing Experiences Also Change Your GenesNews
Factors in early life such as maternal care influence the number and modifications of certain 'jumping genes' - a finding that ties together nature and nurture.READ MORE